L. Grislain

876 total citations
17 papers, 686 citations indexed

About

L. Grislain is a scholar working on Molecular Biology, Pharmacology and Biotechnology. According to data from OpenAlex, L. Grislain has authored 17 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Biotechnology. Recurrent topics in L. Grislain's work include Microbial Inactivation Methods (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). L. Grislain is often cited by papers focused on Microbial Inactivation Methods (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). L. Grislain collaborates with scholars based in France, Switzerland and Belgium. L. Grislain's co-authors include Patrick Couvreur, Marie Cecilie Paasche Roland, P Speiser, Vincent Lenaerts, Boubacar Kanté, Th.J.C. van Berkel, J. Fred Nagelkerke, Claire Guyomard, Alain Fautrel and Christophe Chesné and has published in prestigious journals such as Hepatology, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

L. Grislain

17 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Grislain France 10 284 170 164 95 92 17 686
Manisha Ramaswamy Canada 19 292 1.0× 331 1.9× 145 0.9× 101 1.1× 304 3.3× 28 1.0k
J. Roux France 13 105 0.4× 150 0.9× 82 0.5× 61 0.6× 64 0.7× 26 576
Jinghua Duan United States 14 270 1.0× 252 1.5× 124 0.8× 146 1.5× 64 0.7× 19 702
Vivek Dhawan India 14 354 1.2× 531 3.1× 222 1.4× 230 2.4× 65 0.7× 24 1.2k
Hironao Kobayashi Japan 16 168 0.6× 207 1.2× 136 0.8× 66 0.7× 227 2.5× 26 720
JoEllyn McMillan United States 22 204 0.7× 321 1.9× 120 0.7× 176 1.9× 44 0.5× 36 1.2k
Rishikesh M. Kulkarni United States 8 158 0.6× 224 1.3× 502 3.1× 84 0.9× 119 1.3× 10 965
Henri Vranckx Belgium 8 264 0.9× 178 1.0× 476 2.9× 85 0.9× 61 0.7× 8 777
Himanshu Agrawal India 13 269 0.9× 251 1.5× 310 1.9× 186 2.0× 53 0.6× 34 919
Vincent Boudy France 15 115 0.4× 161 0.9× 246 1.5× 88 0.9× 99 1.1× 39 720

Countries citing papers authored by L. Grislain

Since Specialization
Citations

This map shows the geographic impact of L. Grislain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Grislain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Grislain more than expected).

Fields of papers citing papers by L. Grislain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Grislain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Grislain. The network helps show where L. Grislain may publish in the future.

Co-authorship network of co-authors of L. Grislain

This figure shows the co-authorship network connecting the top 25 collaborators of L. Grislain. A scholar is included among the top collaborators of L. Grislain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Grislain. L. Grislain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aliès, Bruno, Mathieu Gendrot, Alexandra Gaubert, et al.. (2019). Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drug. RSC Advances. 9(33). 18844–18852. 8 indexed citations
2.
Kauss, Tina, Jean‐René Kiechel, Fawaz Fawaz, et al.. (2011). The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. Malaria Journal. 10(1). 142–142. 20 indexed citations
3.
Largeteau, Alain, et al.. (2007). Inactivation ofStaphylococcus aureususing high hydrostatic pressure. High Pressure Research. 27(1). 125–128. 9 indexed citations
4.
Largeteau, Alain, et al.. (2003). Effects of High Hydrostatic Pressure on Several Sensitive Therapeutic Molecules and a Soft Nanodispersed Drug Delivery System. Pharmaceutical Research. 20(12). 2036–2040. 10 indexed citations
5.
Brigger, Irène, Laurence Armand-Lefèvre, Pierre Chaminade, et al.. (2003). The Stenlying Effect of High Hydrostatic Pressure on Thermally and Hydrolytically Labile Nanosized Carriers. Pharmaceutical Research. 20(4). 674–683. 16 indexed citations
6.
Largeteau, Alain, et al.. (2002). Sterilization of Liquid and Semi-Solid Pharmaceutical Forms Using High Pressure Technology. High Pressure Research. 22(3-4). 747–749. 2 indexed citations
7.
Largeteau, Alain, et al.. (2002). Pharmaceuticals Perspectives of High Pressure: A Soft Tool for Sterilization of Fragile Drugs. Defect and diffusion forum/Diffusion and defect data, solid state data. Part A, Defect and diffusion forum. 208-209. 55–58. 3 indexed citations
8.
Lozano, Pedro, et al.. (1994). Comparison of Thymoxamine Permeation between Hairless Rat and Horse Penile Mucous Membrane Using an in vitro Diffusion Model. Skin Pharmacology and Physiology. 7(3). 121–129. 1 indexed citations
9.
Poullain, Marie‐Gwenaelle, Alain Fautrel, Claire Guyomard, et al.. (1992). Viability and primary culture of rat hepatocytes after hypothermic preservation: The superiority of the leibovitz medium over the university of wisconsin solution for cold storage. Hepatology. 15(1). 97–106. 41 indexed citations
10.
Chesné, Christophe, et al.. (1991). Use of cryopreserved animal and human hepatocytes for cytotoxicity studies. Toxicology in Vitro. 5(5-6). 479–482. 14 indexed citations
11.
Grislain, L., et al.. (1990). The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.. Drug Metabolism and Disposition. 18(5). 804–808. 20 indexed citations
12.
Grislain, L., et al.. (1990). Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor. Xenobiotica. 20(8). 787–800. 14 indexed citations
13.
Grislain, L., et al.. (1990). Metabolism of amineptine in rat, dog and man. European Journal of Drug Metabolism and Pharmacokinetics. 15(4). 339–345. 6 indexed citations
14.
Guillouzo, A., L. Grislain, Damrong Ratanasavanh, et al.. (1988). Use of hepatocyte cultures for preliminary metabolism and cytotoxicity studies of a new anti-hypertensive agent, oxaminozoline. Xenobiotica. 18(6). 757–763. 4 indexed citations
15.
Lenaerts, Vincent, J. Fred Nagelkerke, Th.J.C. van Berkel, et al.. (1984). In Vivo Uptake of Polyisobutyl Cyanoacrylate Nanoparticles by Rat Liver Kupffer, Endothelial, andParenchymal Cells. Journal of Pharmaceutical Sciences. 73(7). 980–982. 93 indexed citations
16.
Grislain, L., et al.. (1983). Pharmacokinetics and distribution of a biodegradable drug-carrier. International Journal of Pharmaceutics. 15(3). 335–345. 254 indexed citations
17.
Couvreur, Patrick, Boubacar Kanté, L. Grislain, Marie Cecilie Paasche Roland, & P Speiser. (1982). Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles. Journal of Pharmaceutical Sciences. 71(7). 790–792. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manisha Ramaswamy Breakdown of academic impact, for papers by J. Roux Breakdown of academic impact, for papers by Jinghua Duan Breakdown of academic impact, for papers by Vivek Dhawan Breakdown of academic impact, for papers by Hironao Kobayashi Breakdown of academic impact, for papers by JoEllyn McMillan Breakdown of academic impact, for papers by Rishikesh M. Kulkarni Breakdown of academic impact, for papers by Henri Vranckx Breakdown of academic impact, for papers by Himanshu Agrawal Breakdown of academic impact, for papers by Vincent Boudy
Rankless by CCL
2026